News about the long‑running talc MDL has developed since, but the opinion we discuss today (In re Johnson & Johnson Talcum Powder Prods. Mktg., Sales Pracs., & Prods. Liab. Litig., 2026 U.S. Dist. LEXIS 162870, 2026 LX 335455, 2026 WL 2111340 (D.N.J. July 22, 2026)) is worth a look. It is a prime example of an MDL court exercising its broad authority—nay, obligation—to confront proof problems head‑on.
As we posted a year ago, the term “case vetting order” is growing on us. The term “Lone Pine Order” carries a lot of baggage, and it seems time to stop using the name of a 1986 New Jersey case to refer to a case management procedure for requiring plaintiffs to establish the factual bases for their claims.
Whatever you call them, we have a cheat sheet of favorable orders of this type, and we post about them regularly.
In the memorandum opinion in question, a magistrate judge granted the defendants’ motion for entry of an order to show cause (OSC) why all claims in the proceeding should not be dismissed with prejudice, covering all 69,000 plaintiffs in this MDL alleging that talc causes ovarian cancer.
The order does not itself dismiss any case, but it did declare the intent to force every plaintiff in this decade‑old plaintiff MDL to address a single, central question: Can she establish specific causation with admissible expert testimony under Rule 702?
Collapse of the Specific Causation Evidence in the Bellwether Cases
Earlier in this MDL, the court selected six bellwether cases for full fact and expert discovery and trial. Those bellwether plaintiffs proffered two gynecologic oncologists, Drs. Judith Wolf and Daniel Clarke-Pearson, as specific causation experts.
At a hearing on Rule 702 motions to exclude these experts in May 2026, the wheels came off the bellwether case.
During their testimony, Drs. Wolf and Clarke‑Pearson acknowledged there is no biomarker or reliable method to distinguish talc‑caused ovarian cancer from cancer caused by other risk factors or idiopathic causes, and that this was an “immutable limitation of scientific knowledge.”
Drs. Wolf and Clarke‑Pearson also effectively conceded that “no qualified expert can reliably pinpoint the etiology” of a particular woman’s ovarian cancer, with Dr. Wolf admitting that she did not “know of any way” to rule in or rule out particular risk factors for a given claimant as a differential etiology would require.
Indeed, with Drs. Wolf and Clarke‑Pearson frankly acknowledging that there was no basis for any expert to offer a specific causation opinion that talc caused a particular plaintiff’s cancer, these experts cast doubt on the legitimacy of every case in the entire MDL.
By June 8, 2026, the bellwether plaintiffs had withdrawn Drs. Wolf and Clarke‑Pearson as their specific causation experts, but that was not the end of it.
Defendants filed a motion asking the Court to issue an OSC because the testimony showed that no MDL plaintiff could meet Rule 702 on specific causation, no matter what expert she proffered, and because all the MDL cases—bellwethers and non‑bellwethers alike—seemingly should be dismissed with prejudice for lack of admissible specific causation evidence.
The MDL Plaintiffs’ Steering Committee opposed the motion, no surprise there. It argued that, as to the ~68,994 remaining MDL plaintiffs, a global OSC/case vetting order would violate their due process rights to present individualized experts under their state’s applicable causation standard. It argued that they intended to move to reinstate Drs. Wolf and Clarke‑Pearson as their specific-causation experts. It argued the requested OSC would be a Lone Pine order that was “not an appropriate tool at this stage of the MDL”, and that case-by-case Rule 702 and Rule 56 motions for summary judgment were required. In short, plaintiffs wanted endless expert witness do-overs.
The Court’s Authority to Vet Cases
The Court, however, agreed that an OSC was appropriate. Its opinion began with the Third Circuit’s recognition that MDL courts have “broad discretion” and “significant latitude” to enter case betting orders to manage their dockets and reduce burdens on defendants and the court.
Case‑management orders, including Lone Pine‑type orders and orders to show cause, are expressly aimed at separating meritorious from non‑meritorious claims and promoting just and efficient resolution, and therefore are supported by a surplus of authorities, including:
- 28 U.S.C. § 1407(a) (MDL transfers must promote convenience and “just and efficient conduct”);
- Rule 1 (mandating “just, speedy, and inexpensive” determinations); and
- Rule 16(c)(2)(L) (authorizing “special procedures” in complex, multi‑party, or proof‑heavy cases).
The Court reviewed the factors often weighed in deciding whether a case vetting order is appropriate, from the nature and stage of the litigation, to case‑management concerns, to the availability of other procedures, and case complexity.
As for the “stage” of the MDL, if not now, when? After more than ten years and with more than 69,000 claimants, the talc MDL was anything but nascent; fact and expert discovery on the six bellwethers was fully completed; the record was expansive; and the specific‑causation problems of the Plaintiffs Steering Committee (PSC) only added to the procedural and substantive complexity. Indeed, recently enacted Fed. R. Civ. P. 16.1(a)(3)(B), which did not exist when this MDL was created, suggests that earlier MDL-wide case vetting would be appropriate in this context.
The PSC’s due process objection also met a swift and well-deserved end. Due process requires notice “reasonably calculated” to apprise interested parties and an opportunity to present objections. An order to show cause—indeed, any case vetting order—does exactly that. The existence of other procedural mechanisms (Rule 702 motions, Rule 56 summary judgment, Rule 41 dismissals) is just one consideration, and those tools do not displace a court’s discretion to employ an order to show cause when common, complex issues need to be addressed efficiently and fairly.
At heart, the Court agreed an OSC was appropriate, because it agreed that there were “grave” and “concerning” doubts about whether any individual plaintiff could proffer specific‑causation testimony admissible under Rule 702 (and of course Rule 702 applies in federal court regardless of the applicable substantive state law).
Why An Order To Show Cause, And Why Now
The Court next turned to question of what case‑management mechanism was appropriate to the identified potential common causation problem.
On paper, the court acknowledged, individual Rule 702 and Rule 56 motions in each of the more than 69,000 cases would be theoretically possible, but in practice, that would be neither realistic nor fair. About a decade had already passed with only six cases teed-up for trial. The parties and the Court had invested countless hours and dollars litigating to that point, while hundreds of plaintiffs already had died and the years continued to pass.
The Court was not prepared to leap from deficiencies in two specific-causation experts to the dismissal of the entire MDL, but instead chose a middle path: a global show‑cause process focused squarely on specific causation.
The Court thus granted the defendants’ motion for a show cause order, which the Court expressly characterized this as both equitable and efficient in treating all plaintiffs equally, giving each a chance to be heard, giving defendants a mechanism for challenging unsupported claims en masse, and giving the court a structured way to evaluate the viability of the litigation as a whole. The Court reserved the specifics of the show-cause procedure for a separate, yet-to-come order.
Though the specifics of the show-cause procedure would be interesting to know, you don’t need more than this opinion to see why case vetting orders are so important.
Lawsuits are easy to file, but the complaints on which they are built are little more than hypotheticals built on wishes and maybes. MDL complaints are the most hypothetical and flimsy of all. Whether the PSC in this talc MDL believed all the evidence eventually would line up close enough, or whether they were content to ignore known evidentiary gaps because 69,000 cases alone creates its own gravity, we will never know. But the Court was right to decide to put these cases to the test.
Recent Comments